NCT01144143View on ClinicalTrials.gov

Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

Infliximab

the study drug will be injected into the joint through a needle

DRUG

Placebo

the placebo will be injected into the joint through a needle

DRUG

Standard of Care: Methylprednisolone acetate

Methylprednisolone acetate will be injected into the joint through a needle

Trial Locations (1)

66160

University Of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

Centocor, Inc.
All Listed Sponsors
collaborator

Centocor, Inc.

INDUSTRY

lead

Herbert Lindsley, MD

OTHER